SLAS Discovery

Aims & Scope

Advancing Life Sciences R&D: SLAS Discovery reports how scientists develop and utilize novel technologies and/or approaches to provide and characterize chemical and biological tools to understand and treat human disease.

SLAS Discovery is a peer-reviewed journal that publishes scientific reports that enable and improve target validation, evaluate current drug discovery technologies, provide novel research tools, and incorporate research approaches that enhance depth of knowledge and drug discovery success.

SLAS Discovery emphasizes scientific and technical advances in target identification/validation (including chemical probes, RNA silencing, gene editing technologies); biomarker discovery; assay development; virtual, medium- or high-throughput screening (biochemical and biological, biophysical, phenotypic, toxicological, ADME); lead generation/optimization; chemical biology; and informatics (data analysis, image analysis, statistics, bio- and chemo-informatics).

Review articles on target biology, new paradigms in drug discovery and advances in drug discovery technologies.

SLAS Discovery is of particular interest to those involved in analytical chemistry, applied microbiology, automation, biochemistry, bioengineering, biomedical optics, biotechnology, bioinformatics, cell biology, DNA science and technology, genetics, information technology, medicinal chemistry, molecular biology, natural products chemistry, organic chemistry, pharmacology, spectroscopy, and toxicology.

SLAS Discovery is a member of the Committee on Publication Ethics (COPE) and was published previously (1996-2016) as the Journal of Biomolecular Screening (JBS).

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Chemistry, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Chemistry, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,800.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

  Citation: 6085

  Authors: Ji-Hu, Thomas D.Y., Kevin R.

• High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery

  Citation: 766

  Authors: Michael W., Eugene C., Joseph D., Victor S., James, Edward, Ted, Eric, Barry A., Pamela, F.R.

• Three-Dimensional Cell Cultures in Drug Discovery and Development

  Citation: 675

  Authors: Ye, Richard M.

• The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model

  Citation: 643

  Authors: Leoni A., James P., Ferdinand, Reinhard

• Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis

  Citation: 496

  Authors: Andrea, Manfred

• A Perspective on the Kinetics of Covalent and Irreversible Inhibition

  Citation: 313

  Authors: John M.

• Improved Statistical Methods for Hit Selection in High-Throughput Screening

  Citation: 293

  Authors: Christine, Bert, Bill, Andy

• E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones

  Citation: 276

  Authors: Tasuku, Alessio

• Fluorescence Polarization and Anisotropy in High Throughput Screening: Perspectives and Primer

  Citation: 268

  Authors: John C.

• A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm

  Citation: 268

  Authors: Bernard, Jules C., Najah, Matthew, Khuram W., Thomas, Krystle, William, Bruce, Gul, Gary, John, John, James, Paul, Zhihua, Anders, Carlos A., David, Kohei, David G., Jamie I.